CROSSJECT

XPAR:ALCJ (France)  
€ 2.06 (0%) Nov 27
At Loss
Market Cap:
€ 84.75M ($ 89.36M)
Enterprise V:
€ 102.78M ($ 108.38M)
Volume:
18.79K
Avg Vol (2M):
63.97K
Trade In:
Volume:
18.79K
At Loss

Business Description

Description
CROSSJECT manufactures and markets needle-free drug self-injection system.
Name Current Vs Industry Vs History
Cash-To-Debt 0.25
Equity-to-Asset -0.12
Debt-to-Equity -5.83
Debt-to-EBITDA -2.44
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.13
Distress
Grey
Safe
Beneish M-Score 3.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.1
9-Day RSI 49.29
14-Day RSI 45.97
6-1 Month Momentum % 17.82
12-1 Month Momentum % -45.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.71
Quick Ratio 1.24
Cash Ratio 0.64
Days Inventory 152.09
Days Sales Outstanding 9346.52
Days Payable 181.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.1
Shareholder Yield % -4.74

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -5501.38
Operating Margin % -8477.93
Net Margin % -7226.21
FCF Margin % -8204.14
ROA % -32.84
ROIC % -44.96
ROC (Joel Greenblatt) % -152.98
ROCE % -53.96

GF Value Rank

Name Current Vs Industry Vs History
Forward PE Ratio 9.16
PS Ratio 503.75
EV-to-EBIT -7.64
EV-to-EBITDA -10.44
EV-to-Revenue 708.82
EV-to-FCF -8.49
Earnings Yield (Greenblatt) % -13.09
FCF Yield % -14.04

Financials

XPAR:ALCJ's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CROSSJECT Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.145
EPS (TTM) (€) -0.26
Beta 0.86
Volatility % 71.59
14-Day RSI 45.97
14-Day ATR (€) 0.102455
20-Day SMA (€) 2.03225
12-1 Month Momentum % -45.43
52-Week Range (€) 1.52 - 5.908004
Shares Outstanding (Mil) 41.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CROSSJECT Filings

Filing Date Document Date Form
No Filing Data

CROSSJECT Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

CROSSJECT Frequently Asked Questions

What is CROSSJECT(XPAR:ALCJ)'s stock price today?
The current price of XPAR:ALCJ is €2.06. The 52 week high of XPAR:ALCJ is €5.91 and 52 week low is €1.52.
When is next earnings date of CROSSJECT(XPAR:ALCJ)?
The next earnings date of CROSSJECT(XPAR:ALCJ) is .
Does CROSSJECT(XPAR:ALCJ) pay dividends? If so, how much?
CROSSJECT(XPAR:ALCJ) does not pay dividend.

Press Release

Subject Date
No Press Release